在家隔离计划中的COVID-19患者中的肺功能
Narongkorn Saiphoklang1,2,3, Pitchayapa Ruchiwit1, Apichart Kanitsap1
1Department of Internal Medicine, Faculty of Medicine, Thammasat University, Pathum Thani 12120, Thailand.
Medical sciences (Basel, Switzerland)
|July 23, 2025
概括
轻度的COVID-19可以导致持久的肺功能问题,即使在家中治疗的患者中也是如此. 近三分之一的参与者显示肺功能异常,主要是限制性模式和小呼吸道疾病,突出显示需要长期监测.
科学领域:
- 肺部病理学 肺部病理学
- 传染性疾病 传染性疾病
- 公共卫生 公共卫生
背景情况:
- 2019年轻型冠状病毒病 (COVID-19) 患者通常被视为门诊患者.
- 在这个人口群体中,肺功能仍未得到充分探索.
- 这项研究调查了在家中隔离的COVID-19患者的肺功能异常.
研究的目的:
- 为了确定在家庭隔离下管理的轻度COVID-19患者中异常肺功能的患病率和类型.
- 在基线和3个月后的随访中评估肺功能变化.
主要方法:
- 一项前性研究涉及250名无症状或轻度COVID-19患者,胸部X射线图正常.
- 包括FEV1,FVC,PEF,FEF25-75和BDR在内的螺旋测量测量在基线和3个月后随访时收集.
- 异常的肺功能被分类为特定的模式,如气道阻塞和限制性缺陷.
主要成果:
- 28.4%的患者表现出异常的肺功能,主要是限制性模式 (14.4%) 和小呼吸道疾病 (8.4%).
- 与基线相比,观察到FVC,FEV1/FVC比率,PEF和FEF25-75.5的显著变化.
- 较高的体重指数与异常肺功能风险降低相关.
结论:
- 轻度COVID-19门诊患者中很大一部分患有残留肺功能障碍.
- 限制性模式和小呼吸道疾病是观察到的最常见的呼吸系统缺陷.
- 需要进一步的长期研究,以了解轻度的COVID-19对肺部健康的全部影响.
相关概念视频
Pulmonary Function Tests
435
Pulmonary Function Tests (PFTs)
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
435
Chronic Obstructive Pulmonary Disease
1.4K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.4K
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.6K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.6K
Chronic Obstructive Pulmonary Disease-V: Management
2.7K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.7K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
3.1K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
3.1K
Chronic Obstructive Pulmonary Disease-I: Introduction
2.9K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.9K


